Form D · Other Technology
Vye Health Inc.
San Francisco, CA · CIK 0002158121
Offering snapshot reported Oct 8, 2026 · SEC filing
- Reported sold
- $16.2M Offering amount: $18.2M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2026 | Initial | $16,234,993 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600540
Source: Form D, filed Oct 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Corey Lenhoff | Director |
| Matthew Vail | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
455 Market Street Ste 1940
San Francisco, CA, 94105
San Francisco, CA, 94105